Literature DB >> 26148201

Evaluation of Flibanserin: Science and Advocacy at the FDA.

Walid F Gellad1, Kathryn E Flynn2, G Caleb Alexander3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26148201     DOI: 10.1001/jama.2015.8405

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients.

Authors:  Sheriza N Baksh; Walid F Gellad; G Caleb Alexander
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

2.  Flibanserin: Approval of a controversial drug for a controversial disorder.

Authors:  T S Sathyanarayana Rao; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2015 Jul-Sep       Impact factor: 1.759

Review 3.  Female sexual dysfunction: a focus on flibanserin.

Authors:  Nicole M Lodise
Journal:  Int J Womens Health       Date:  2017-10-11

4.  Modeling Human Sexual Motivation in Rodents: Some Caveats.

Authors:  Olivia Le Moëne; Anders Ågmo
Journal:  Front Behav Neurosci       Date:  2019-08-27       Impact factor: 3.558

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.